Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKD

INTRODUCTION: Soluble urokinase plasminogen activation receptor (suPAR) is an immune-derived pathogenic factor for kidney and atherosclerotic disease. Whether the association between suPAR and cardiovascular (CV) outcomes is dependent on the severity of underlying kidney disease is unclear. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommerer, Claudia, Müller-Krebs, Sandra, Nadal, Jennifer, Schultheiss, Ulla T., Friedrich, Nele, Nauck, Matthias, Schmid, Matthias, Nußhag, Christian, Reiser, Jochen, Eckardt, Kai-Uwe, Zeier, Martin, Hayek, Salim S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658273/
https://www.ncbi.nlm.nih.gov/pubmed/38025216
http://dx.doi.org/10.1016/j.ekir.2023.08.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658273/
https://www.ncbi.nlm.nih.gov/pubmed/38025216
http://dx.doi.org/10.1016/j.ekir.2023.08.038

Ejemplares similares